Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. (Q45088794)
Jump to navigation
Jump to search
scientific article published on 27 August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. |
scientific article published on 27 August 2005 |
Statements
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial (English)
Jens Overgaard
Marianne Nordsmark
Danish Head and Neck Cancer Study Group
27 August 2005